Strategies for immune regulation in iPS cell-based cardiac regenerative medicine

Cardiac regenerative therapy is expected to be a promising therapeutic option for the treatment of severe cardiovascular diseases. Artificial tissues or organoids made from cardiovascular cell lineages differentiated from human induced pluripotent stem cells (iPSCs) are expected to regenerate the da...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Kozue, Ikegawa, Masaya, Minatoya, Kenji, Masumoto, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523082/
https://www.ncbi.nlm.nih.gov/pubmed/33005258
http://dx.doi.org/10.1186/s41232-020-00145-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523082/
https://www.ncbi.nlm.nih.gov/pubmed/33005258
http://dx.doi.org/10.1186/s41232-020-00145-4

Ejemplares similares